Helicon Health provides first public glimpse of Digital Clinical Trials

Helicon Health has selected the new HTN Digital Health Playbook (PDF) to do a partial reveal on the first in a long line of Digital Clinical Trials and new product developments. Designed to stimulate constructive engagement, Helicon reveal elements of key projects, case studies, learnings and solutions – all contributing to its mission of “Delivering Health Virtually”.

Prof David Patterson, Founder and Chief Medical Officer at Helicon Health – “In this edition of the HTN Playbook we describe our work on the Epigastric Impedance Monitor (the EIM), which fills a large and unmet need in the field of the malfunctioning stomach, where there is no method for measuring gastric emptying suitable for primary care or paediatrics. That means a patient’s condition cannot be assessed objectively or progress monitored. The EIM fills this need by being completely non-invasive, simple to operate and inexpensive to run. It resembles the gastric equivalent of the electrocardiograph for the heart”.

Download the HTN Digital Health Playbook (PDF)

More Helicon News

About the Author
Tony Bowden
As CEO, Director and Shareholder the buck stops with me. I thank all our valued Customers, Partners, Shareholders and Team members for their continued support.
Share this post
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share This